A randomized, single-dose, double-blind, placebo-controlled, ascending dose, 4-way crossover study to evaluate the analgesic effects of ViphyllinTM in healthy volunteers.

Vidya Herbs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年6月27日

试验速览

暂无简介。

•1. Should not be on any regular medications or supplementation for pain.
•2. Must be willing and able to give informed consent and comply with the study procedures.
•3. Should be ready to abstain from alcohol consumption, smoking and consumption of caffeinated beverages.

•1.Subjects who are experiencing pain currently due to any cause or with history of acute or chronic pain.
•2. Subject with ability to withstand the CPT for the maximum 3 minutes (to avoid a ceiling effect).
•3. Subjects having symptoms of viral infection, including COVID-19 infection
•4. Subject with clinically significant abnormalities in blood pressure, heart rate, ECG recording and laboratory parameters
•5. Regularly on over the counter or prescribed medication
•6. Subjects with known hypersensitivity to the investigational products.
•7. Alcohol/drug addicts, smokers of more than 10 cigarettes/day.
•8. Pregnant and lactating women
•9. Currently participating or having participated in another clinical trial during the last 1 month prior to the beginning of this study
•10. Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study.

发起方